Fatih M. Uckun
94Patents
21h-index
37Co-inventors
88Inventor score
Filing activity: Jan 3, 1986 → May 10, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6160010A | BTK inhibitors and methods for their identification and use | Human Necessities | 164 | Expired |
| US6753348B2 | BTK inhibitors and methods for their identification and use | Human Necessities | 112 | Expired |
| US6221900A | BTK inhibitors and methods for their identification and use | Human Necessities | 102 | Expired |
| US6080747A | JAK-3 inhibitors for treating allergic disorders | Human Necessities | 100 | Expired |
| US6168932A | Recombinant DTctGMCSF fusion toxin in a baculovirus expression vector system | Chemistry; Metallurgy | 84 | Expired |
| US6177433A | JAK-3 inhibitors for treating allergic disorders | Human Necessities | 74 | Expired |
| US6313130A | JAK-3 inhibitors for treating allergic disorders | Human Necessities | 62 | Expired |
| US6080748A | Therapeutic use of JAK-3 inhibitors | Human Necessities | 61 | Expired |
| US6306897A | Calanolides for inhibiting BTK | Chemistry; Metallurgy | 48 | Expired |
| US6303652A | BTK inhibitors and methods for their identification and use | Human Necessities | 41 | Expired |
| US5587459A | Immunoconjugates comprising tyrosine kinase inhibitors | Human Necessities | 35 | Expired |
| US6495556B2 | Dimethoxy quinazolines for treating diabetes | Chemistry; Metallurgy | 34 | Expired |
| US6469013B2 | Therapeutic compounds | Chemistry; Metallurgy | 34 | Expired |
| US6358962B2 | 6,7-Dimethoxyquinazolines and therapeutic use thereof | Human Necessities | 28 | Expired |
| US6248790A | Treatment of inflammation with 2,4,6-trihydroxy-alpha-rho-methoxyphenylacetophenone, or its pharmaceutically acceptable derivatives | Human Necessities | 28 | Expired |
| US6326373A | JAK-3 inhibitors for treating allergic disorders | Human Necessities | 27 | Expired |
| US6313129A | Therapeutic compounds | Chemistry; Metallurgy | 26 | Expired |
| US6605589B1 | Cathepsin inhibitors in cancer treatment | Human Necessities | 24 | Expired |
| US6552027B2 | Quinazolines for treating brain tumor | Chemistry; Metallurgy | 24 | Expired |
| US5911995A | EGF-genistein conjugates for the treatment of cancer | Human Necessities | 21 | Expired |
| US6316454A | 6,7-Dimethoxy-4-anilinoquinazolines | Chemistry; Metallurgy | 21 | Expired |
| US5872223A | Immunoconjugates comprising tyrosine kinase inhibitors | Human Necessities | 19 | Expired |
| US6191123A | Organic-arsenic compounds | Human Necessities | 16 | Expired |
| US6030957A | Aryl phosphate derivatives of d4T having anti-HIV activity | Chemistry; Metallurgy | 15 | Expired |
| US4831117A | Monoclonal antibody specific for human B-cells | Emerging Cross-Sectional Technologies | 15 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.